1. Home
  2. ONC vs FERG Comparison

ONC vs FERG Comparison

Compare ONC & FERG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • FERG
  • Stock Information
  • Founded
  • ONC 2010
  • FERG 1887
  • Country
  • ONC Switzerland
  • FERG United States
  • Employees
  • ONC N/A
  • FERG N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • FERG Miscellaneous
  • Sector
  • ONC Health Care
  • FERG Miscellaneous
  • Exchange
  • ONC Nasdaq
  • FERG Nasdaq
  • Market Cap
  • ONC 26.9B
  • FERG 32.1B
  • IPO Year
  • ONC N/A
  • FERG N/A
  • Fundamental
  • Price
  • ONC $245.58
  • FERG $182.23
  • Analyst Decision
  • ONC Strong Buy
  • FERG Buy
  • Analyst Count
  • ONC 7
  • FERG 13
  • Target Price
  • ONC $326.43
  • FERG $200.15
  • AVG Volume (30 Days)
  • ONC 368.4K
  • FERG 1.4M
  • Earning Date
  • ONC 05-07-2025
  • FERG 06-03-2025
  • Dividend Yield
  • ONC N/A
  • FERG 1.82%
  • EPS Growth
  • ONC N/A
  • FERG N/A
  • EPS
  • ONC N/A
  • FERG 8.13
  • Revenue
  • ONC $4,180,740,829.00
  • FERG $29,898,000,000.00
  • Revenue This Year
  • ONC $32.78
  • FERG $4.15
  • Revenue Next Year
  • ONC $19.07
  • FERG $5.13
  • P/E Ratio
  • ONC N/A
  • FERG $22.41
  • Revenue Growth
  • ONC 52.09
  • FERG 1.84
  • 52 Week Low
  • ONC $141.31
  • FERG $146.00
  • 52 Week High
  • ONC $287.88
  • FERG $225.63
  • Technical
  • Relative Strength Index (RSI)
  • ONC N/A
  • FERG 61.60
  • Support Level
  • ONC N/A
  • FERG $176.26
  • Resistance Level
  • ONC N/A
  • FERG $184.60
  • Average True Range (ATR)
  • ONC 0.00
  • FERG 3.27
  • MACD
  • ONC 0.00
  • FERG 0.06
  • Stochastic Oscillator
  • ONC 0.00
  • FERG 77.54

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.

About FERG Ferguson plc

Ferguson distributes plumbing and HVAC products to North American repair, maintenance and improvement, new construction, and civil infrastructure markets. It serves over 1 million customers and sources products from 36,000 suppliers. Ferguson engages customers through approximately 1,800 North American branches, over the phone, online, and in residential showrooms. According to Modern Distribution Management, Ferguson is the largest plumbing distributor and second-largest HVAC distributor (next to Watsco) in North America. The firm sold its UK business in 2021 and is now solely focused on the North American market.

Share on Social Networks: